RMEBX
Price
$57.64
Change
-$0.04 (-0.07%)
Updated
Jun 5 closing price
Net Assets
105.31B
USISX
Price
$17.81
Change
-$0.02 (-0.11%)
Updated
Jun 5 closing price
Net Assets
2.46B
Interact to see
Advertisement

RMEBX vs USISX

Header iconRMEBX vs USISX Comparison
Open Charts RMEBX vs USISXBanner chart's image
American Funds American Mutual R2E
Price$57.64
Change-$0.04 (-0.07%)
VolumeN/A
Net Assets105.31B
Victory Income Stock
Price$17.81
Change-$0.02 (-0.11%)
VolumeN/A
Net Assets2.46B
RMEBX vs USISX Comparison Chart
Loading...
View a ticker or compare two or three
VS
RMEBX vs. USISX commentary
Jun 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RMEBX is a Buy and USISX is a StrongBuy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RMEBX has more cash in the bank: 105B vs. USISX (2.46B). USISX pays higher dividends than RMEBX: USISX (1.92) vs RMEBX (1.16). RMEBX was incepted earlier than USISX: RMEBX (11 years) vs USISX (38 years). RMEBX (1.07) is less costly to investors than USISX (0.75). USISX is a more actively managed with annual turnover of: 58.00 vs. RMEBX (31.00). RMEBX has a lower initial minimum investment than USISX: RMEBX (250) vs USISX (3000). RMEBX annual gain was more profitable for investors over the last year : 8.30 vs. USISX (-7.37). RMEBX return over 5 years is better than : 49.85 vs. USISX (24.28).
RMEBXUSISXRMEBX / USISX
Total Expense Ratio1.070.75143%
Annual Report Gross Expense Ratio1.070.75143%
Fund Existence11 years38 years-
Gain YTD5.3491.578339%
Front LoadN/AN/A-
Min. Initial Investment25030008%
Min. Initial Investment IRAN/AN/A-
Net Assets105B2.46B4,275%
Annual Yield % from dividends1.161.9260%
Returns for 1 year8.30-7.37-113%
Returns for 3 years17.96-0.66-2,703%
Returns for 5 years49.8524.28205%
Returns for 10 years68.2114.48471%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
VERV5.720.43
+8.22%
Verve Therapeutics
VRNT18.780.97
+5.45%
Verint Systems
CHRS0.80N/A
+0.48%
Coherus Oncology Inc
CHSCN25.15-0.05
-0.20%
CHS
PRI265.13-2.99
-1.12%
PRIMERICA